SG Americas Securities’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-32,520
| Closed | -$97K | – | 2555 |
|
|
2025
Q1 | $97K | Buy |
32,520
+422
| +1% | +$1.26K | ﹤0.01% | 2713 |
|
|
2024
Q4 | $108K | Buy |
32,098
+1,486
| +5% | +$5K | ﹤0.01% | 2399 |
|
|
2024
Q3 | $103K | Buy |
30,612
+16,561
| +118% | +$55.7K | ﹤0.01% | 2712 |
|
|
2024
Q2 | $47K | Sell |
14,051
-14,089
| -50% | -$47.1K | ﹤0.01% | 2317 |
|
|
2024
Q1 | $114K | Sell |
28,140
-14,381
| -34% | -$58.3K | ﹤0.01% | 2180 |
|
|
2023
Q4 | $130K | Buy |
42,521
+8,024
| +23% | +$24.5K | ﹤0.01% | 2318 |
|
|
2023
Q3 | $103K | Buy |
+34,497
| New | +$103K | ﹤0.01% | 2517 |
|
|
2023
Q2 | – | Sell |
-31,179
| Closed | -$104K | – | 1982 |
|
|
2023
Q1 | $104K | Sell |
31,179
-7,863
| -20% | -$26.2K | ﹤0.01% | 2631 |
|
|
2022
Q4 | $188K | Sell |
39,042
-39,797
| -50% | -$192K | ﹤0.01% | 2030 |
|
|
2022
Q3 | $449K | Buy |
78,839
+13,519
| +21% | +$77K | 0.01% | 1444 |
|
|
2022
Q2 | $464K | Buy |
+65,320
| New | +$464K | ﹤0.01% | 1835 |
|
|
2022
Q1 | – | Sell |
-17,361
| Closed | -$155K | – | 2585 |
|
|
2021
Q4 | $155K | Sell |
17,361
-20,323
| -54% | -$181K | ﹤0.01% | 2529 |
|
|
2021
Q3 | $1.32M | Buy |
+37,684
| New | +$1.32M | 0.01% | 1521 |
|
|
2021
Q2 | – | Sell |
-2,119
| Closed | -$131K | – | 2508 |
|
|
2021
Q1 | $131K | Buy |
+2,119
| New | +$131K | ﹤0.01% | 2676 |
|